Clinical Trial Update: Safety And Efficacy Of Bosutinib

View source ↗

Summary

This Clinical Trial Update reports on the safety and efficacy outcomes of bosutinib in patients with chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Chronic Myelogenous Leukemia | Status: COMPLETED